Claudio Arrigoni

450 total citations
13 papers, 148 citations indexed

About

Claudio Arrigoni is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Claudio Arrigoni has authored 13 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Claudio Arrigoni's work include Inflammatory mediators and NSAID effects (2 papers), Chemical synthesis and alkaloids (2 papers) and Cancer therapeutics and mechanisms (1 paper). Claudio Arrigoni is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Chemical synthesis and alkaloids (2 papers) and Cancer therapeutics and mechanisms (1 paper). Claudio Arrigoni collaborates with scholars based in Italy, United States and Sweden. Claudio Arrigoni's co-authors include Patrizia Crivori, Andrea Terron, Tae‐Won Kim, Susan E. Turnquist, Robert H. Denlinger, Winston Evering, Shem Patyna, Steven Vonderfecht, Mario Varasi and Antonio Pillan and has published in prestigious journals such as Journal of Medicinal Chemistry, Pharmacological Research and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Claudio Arrigoni

12 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudio Arrigoni Italy	5	65	37	29	25	19	13	148
Leticia Cuarental Spain	9	82 1.3×	15 0.4×	13 0.4×	8 0.3×	17 0.9×	12	240
Luke Green Switzerland	6	81 1.2×	33 0.9×	11 0.4×	39 1.6×	6 0.3×	7	200
Luisa Averdunk Germany	8	44 0.7×	13 0.4×	35 1.2×	6 0.2×	26 1.4×	11	223
Alexandre Ceccaldi France	10	309 4.8×	12 0.3×	35 1.2×	25 1.0×	33 1.7×	16	405
Bruno Lorusso Italy	7	49 0.8×	87 2.4×	7 0.2×	27 1.1×	24 1.3×	21	199
Hong Xiao China	8	66 1.0×	40 1.1×	7 0.2×	44 1.8×	59 3.1×	14	240
Sandy Ferber United States	7	133 2.0×	110 3.0×	20 0.7×	6 0.2×	24 1.3×	9	277
Yinglong Hou China	10	97 1.5×	19 0.5×	135 4.7×	8 0.3×	10 0.5×	19	278
Zeina N. Al-Mahayri United Arab Emirates	9	52 0.8×	54 1.5×	21 0.7×	4 0.2×	25 1.3×	17	226
Chi‐Wen Tu Taiwan	8	52 0.8×	43 1.2×	6 0.2×	9 0.4×	19 1.0×	21	141

Countries citing papers authored by Claudio Arrigoni

Since Specialization

Citations

This map shows the geographic impact of Claudio Arrigoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Arrigoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Arrigoni more than expected).

Fields of papers citing papers by Claudio Arrigoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Arrigoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Arrigoni. The network helps show where Claudio Arrigoni may publish in the future.

Co-authorship network of co-authors of Claudio Arrigoni

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Arrigoni. A scholar is included among the top collaborators of Claudio Arrigoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Arrigoni. Claudio Arrigoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Patyna, Shem, Claudio Arrigoni, Andrea Terron, et al.. (2008). Nonclinical Safety Evaluation of Sunitinib: A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET Receptors. Toxicologic Pathology. 36(7). 905–916. 67 indexed citations

Arrigoni, Claudio, et al.. (2008). Evaluation of long term effects of an intracardiac implant for ECG recording in conscious monkeys. Journal of Pharmacological and Toxicological Methods. 58(2). 153–154. 2 indexed citations

Nomura, Shunji, et al.. (2006). Munehiro Hashimoto, Ph. D. (November 9, 1955-September 23, 2005) - In memoriam. Journal of Pharmacological and Toxicological Methods. 54(2). 91–93. 2 indexed citations

Arrigoni, Claudio & Patrizia Crivori. (2006). Assessment of QT liabilities in drug development. Cell Biology and Toxicology. 23(1). 1–13. 18 indexed citations

Nomura, Shunji, et al.. (2006). In memoriam. Journal of Pharmacological and Toxicological Methods. 54(2). 91–93. 1 indexed citations

Torre, Paola Della, et al.. (2001). PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential. Cancer Chemotherapy and Pharmacology. 47(4). 355–360. 8 indexed citations

Geroni, Cristina, Marina Ripamonti, Claudio Arrigoni, et al.. (2001). Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.. PubMed. 61(5). 1983–90. 17 indexed citations

Pillan, Antonio, Vittorio Pinciroli, Claudio Arrigoni, et al.. (1997). Phenylimidazolidin-2-one Derivatives as Selective 5-HT₃Receptor Antagonists and Refinement of the Pharmacophore Model for 5-HT₃Receptor Binding. Journal of Medicinal Chemistry. 40(21). 3369–3380. 24 indexed citations

Arrigoni, Claudio, et al.. (1992). Effects of ADR-932, a long-lasting 5-HT3 antagonist, on bezold-jarisch reflex in rats and cisplatin emesis in dogs. Pharmacological Research. 26. 319–319. 1 indexed citations

10.

Sartorelli, P., et al.. (1990). Metyrapone and Adrenal Response in Stressed Calves*. Journal of Veterinary Medicine Series A. 37(1-10). 771–774. 4 indexed citations

11.

Arrigoni, Claudio, et al.. (1989). Antiulcer and antisecretory ergoline derivatives.. PubMed. 44(1). 39–50. 1 indexed citations

12.

Arrigoni, Claudio, et al.. (1984). Cytoprotective and antisecretory effects of 11-deoxy-13,14-didehydro16(s)-methyl PGE2 methylester (FCE 20700). Prostaglandins Leukotrienes and Medicine. 15(1). 79–89. 2 indexed citations

13.

Ceserani, R., et al.. (1983). FCE 20700, a cytoprotective PGE2 derivative, does not interfere with the antiinflammatory activity of indomethacin.. PubMed. 5(4). 349–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact